McLaren Health Care, the three-state health care provider operating hospitals and comprehensive medical campuses throughout Michigan, has established the McLaren Heart & Vascular Institute (MHVI) to unify McLaren’s 12 hospital-based cardiology, vascular, and cardiothoracic services and cardiovascular diagnosis, treatment, and prevention.
Through the MHVI, the collaboration by cardiovascular physicians and surgeons will position McLaren heart and vascular programs throughout the state, including McLaren Bay Region, Thumb Region, and Caro Region, to expand their services and advance the therapies they can provide their communities.
“We are pleased to be expanding heart and vascular care at McLaren Bay, Thumb, and Caro,” said Dr. Daniel Lee, Interventional Cardiologist. “All of these locations will be benefiting from this collaboration, bringing each of these communities the very best cardiovascular care by increasing access to new technologies and clinical research.”
Together, the institute will also develop and implement clinical practice guidelines, performance benchmarks, and enhance the partnerships that exist across McLaren facilities.
Interventional cardiologist Samer Y. Kazziha, MD, FACP, FACC, FSCAI, FCCP, FSVMB, will lead the initiative as its Chief Medical Director.
“Dr. Kazziha brings an extensive and beneficial blend of clinical and administrative experience that can effectively position our teams to advance the level of cardiovascular care in the communities we serve and increase the therapies offered to our patients,” said Dr. Justin Klamerus, McLaren Health Care Executive Vice President and Chief Clinical Officer. “His career has been highlighted by establishing and leading strong cardiovascular programs in Southeast Michigan.”
McLaren cardiovascular programs throughout the state have routinely expanded their care offerings, often introducing the latest technologies and procedures to the communities they service, including such advanced, minimally invasive procedures as TAVR, Watchman, T-CAR, and WEB, among others, that address common, quality-of-life-limiting and potentially life-threatening conditions.
“With our shared vision for providing the best possible care for each patient through access and innovation, I am excited to join McLaren and work with this exceptional program and team of providers,” Kazziha said. “With the development and aim of this institute, I believe we can make a significant and positive impact on the lives and health of so many across Michigan.”